Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.

Schetelig, JohannesChevallier, Patricevan Gelder, MichelHoek, JenniferHermine, OlivierChakraverty, RonjonBrowne, PaulMilpied, NoelMalagola, MicheleSocié, GerardDelgado, JulioDeconinck, EricDamaj, GhandiMaury, SebastianBeelen, DietrichQuoc, Stéphanie NguyenShankara, PaneeshaBrecht, ArneMayer, JiriHunault-Berger, MathildeBittenbring, JörgThieblemont, CatherineLepretre, StéphaneBaldauf, Henningde Wreede, Liesbeth CTournilhac, OlivierYakoub-Agha, IbrahimKröger, NicolausDreger, Peter2024-07-192024-07-192022-02Schetelig J, Chevallier P, van Gelder M, Hoek J, Hermine O, Chakraverty R, Browne P, Milpied N, Malagola M, Socié G, Delgado J, Deconinck E, Damaj G, Maury S, Beelen D, Quoc SN, Shankara P, Brecht A, Mayer J, Hunault-Berger M, Bittenbring J, Thieblemont C, Lepretre S, Baldauf H, de Wreede LC, Tournilhac O, Yakoub-Agha I, Kröger N, Dreger P. Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party. Bone Marrow Transplant. 2022 Feb;57(2):330. doi: 10.1038/s41409-021-01516-2. Erratum for: Bone Marrow Transplant. 2021 Mar;56(3):605-613. doi: 10.1038/s41409-020-01069-w0268-33691476-536510.1038/s41409-021-01516-234773088http://hdl.handle.net/20.500.14200/5198No abstract availableenOncology. Pathology.Microbiology. ImmunologyTransplantationCorrection to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.Correspondence